Psychopharmacology Flashcards
Data collected in a survey of 242 million adults in the United States indicated that about ____ in ____ adults had filled one or more prescriptions for psychiatric drugs in 2013 (Moore & Mattison, 2016). In terms of type of drug, the largest number of adults reported filling prescriptions for ________ (12%), followed by ________ (8.3%) and ________ (1.6 percent).
- 1 in 6
- antidepressants
- anxiolytics, sedatives, and hypnotics
- antipsychotics
The first-generation antipsychotics (FGAs) are also known as traditional and conventional antipsychotics and include:
- chlorpromazine (Thorazine)
- haloperidol (Haldol)
- thioridazine (Mellaril)
- fluphenizine (Prolixin)
FGAs are used to treat ________ and other disorders with psychotic symptoms and are more effective for treating ________ than ________.
- schizophrenia
- positive symptoms
- negative symptoms
The FGAs exert their therapeutic effects primarily by:
blocking dopamine (especially D2) receptors
The major side effects of the FGAs fall into three categories:
1) Anitcholinergic sides effects: (e.g., chlorpromazine and thioridazine)
2) Extrapyramidal side effects
3) Neuroleptic malignant syndrome (NMS)
Anticholinergic side effects are most likely with ________ (e.g., chlorpromazine and thioridazine) and include ________, ________, ________, ________, and ________.
- low potency FGAs
- dry mouth
- blurred vision
- urinary retention
- constipation
- tachycardia
Extrapyramidal side effects are most likely with ________ (e.g., haloperidol and fluphenizine) and include ________, ________, ________, and ________.
- high-potency FGAs
- parkinsonism (resting tremor, muscle rigidity, slowed movement)
- dystonia (uncontrollable muscle contractions)
- akathisia (a sense of inner restlessness)
- tardive dyskinesia (involuntary, rhythmic movements of the tongue, face, and jaw and, over time, may also affect the limbs and trunk)
Tardive dyskinesia is:
- potentially life threatening
- begins after long-term drug use
- more common in women and older adults
- irreversible
- treated by gradually withdrawing the drug, administering a benzodiazepine, or switching to a second-generation antipsychotic
Neuroleptic malignant syndrome (NMS) is a rare life-threatening side effect from FGA use. Its symptoms include ________, ________, ________, and ________.
- muscle rigidity
- a high fever
- autonomic dysfunction (e.g., unstable blood pressure, tachycardia, excessive sweating)
- an altered mental state (e.g., confusion, combativeness)
Treatment for neuroleptic malignant syndrome (NMS) involves:
having the person stop taking the drug at the first sign of symptoms and providing him/her with supportive therapy (e.g., hydration, cooling).
The second-generation antipsychotics (SGAs) are also known as atypical antipsychotics and include:
- clozapine (Clozaril)
- risperidone (Risperdal)
- olanzapine (Zyprexa)
- quetiapine (Seroquel)
- aripiprazole (Abilify)
Like the FGAs, SGAs are used to treat ________ and other disorders with ________ symptoms, and some are FDA-approved as an adjunctive treatment for ________.
schizophrenia
psychotic
major depressive disorder
SGAs are as effective as or more effective than the FGAs for treating the ________ of schizophrenia and more effective than the FGAs for treating the ________, although this may be true for only some SGAs. In addition, an SGA (especially ________) may be effective when ________.
positive symptoms
negative symptoms
clozapine
FGAs have been ineffective
SGAs alleviate positive symptoms primarily by ________ and alleviate negative and cognitive symptoms primarily by ________.
- blocking dopamine (especially D3 and D4) receptors
- blocking serotonin receptors
The SGAs are ________ than the FGAs to cause ________; however, they can cause anticholinergic effects, neuroleptic malignant syndrome, and metabolic syndrome
less likely
extrapyramidal side effects
Metabolic syndrome from SGA use involves:
- substantial weight gain
- high blood pressure
- insulin resistance
- hyperglycemia
- increased risk for diabetes mellitus and heart disease
Clozapine and, to a lesser extent, other SGAs can cause agranulocytosis, which is:
- a potentially life-threatening condition that involves a dangerously low white blood cell count
- requires regular white blood cell monitoring
The major antidepressants include:
- selective serotonin reuptake inhibitors (SSRIs)
- serotonin and norepinephrine reuptake inhibitors (SNRIs)
- norepinephrine dopamine reuptake inhibitors (NDRIs)
- tricyclic antidepressants (TCAs)
- monoamine oxidase inhibitors (MAOIs)
The SSRIs include:
- fluoxetine (Prozac, Sarafem)
- fluvoxamine (Luvox)
- paroxetine (Paxil)
- sertraline (Zoloft),
- citalopram (Celexa)